IPSEN - Buy-Back Programme - Art 5 Of MAR - Week 39 - 2025

2025-09-30 12:31:32

(MENAFN- GlobeNewsWire - Nasdaq)

Aggregated presentation by day and by market Statement of transactions in own shares from September 22nd to September 26th 2025

Name of the issue	Identity code of the issuer (Legal Entity Identifier)	Day of the transaction	Identity code of the financial instrument	Total daily volume (in number of shares)	Daily weighted average purchase price of the shares	Market (MIC Code)
IPSEN	549300M6SGDPB4Z94P11	22/09/2025	FR0010259150	300	115,90	AQEU
IPSEN	549300M6SGDPB4Z94P11	22/09/2025	FR0010259150	600	116,30	CCXE
IPSEN	549300M6SGDPB4Z94P11	22/09/2025	FR0010259150	300	116,20	TQEX
IPSEN	549300M6SGDPB4Z94P11	22/09/2025	FR0010259150	3400	115,85629	XPAR
IPSEN	549300M6SGDPB4Z94P11	23/09/2025	FR0010259150	275	112,62727	AQEU
IPSEN	549300M6SGDPB4Z94P11	23/09/2025	FR0010259150	1167	113,15596	CCXE
IPSEN	549300M6SGDPB4Z94P11	23/09/2025	FR0010259150	235	112,64681	TQEX
IPSEN	549300M6SGDPB4Z94P11	23/09/2025	FR0010259150	2923	113,84872	XPAR
IPSEN	549300M6SGDPB4Z94P11	24/09/2025	FR0010259150	185	115,08649	AQEU
IPSEN	549300M6SGDPB4Z94P11	24/09/2025	FR0010259150	1013	114,95716	CCXE
IPSEN	549300M6SGDPB4Z94P11	24/09/2025	FR0010259150	148	114,99797	TQEX
IPSEN	549300M6SGDPB4Z94P11	24/09/2025	FR0010259150	3254	115,17560	XPAR
IPSEN	549300M6SGDPB4Z94P11	25/09/2025	FR0010259150	290	111,80	AQEU
IPSEN	549300M6SGDPB4Z94P11	25/09/2025	FR0010259150	1625	111,78258	CCXE
IPSEN	549300M6SGDPB4Z94P11	25/09/2025	FR0010259150	248	111,86774	TQEX
IPSEN	549300M6SGDPB4Z94P11	25/09/2025	FR0010259150	2637	112,50076	XPAR
IPSEN	549300M6SGDPB4Z94P11	26/09/2025	FR0010259150	124	110,76935	AQEU
IPSEN	549300M6SGDPB4Z94P11	26/09/2025	FR0010259150	3476	111,10964	XPAR
				22200	113,67438

Attachment

EN_IPSEN - Buy-back programme - Art 5 of MAR - Week 39_2025

MENAFN30092025004107003653ID1110131589

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.